期刊文献+

子宫颈癌患者血清TGF-β1表达的临床意义

下载PDF
导出
摘要 目的 研究子宫颈癌患者血清中转化生长因子β1(TGF - β1)表达意义及其与临床分期的关系。方法 以酶联免疫法检测 83例子宫颈癌患者 (观察组 )及 4 0例体检健康妇女 (对照组 )血清中TGF - β1的含量。结果 观察组血清中TGF - β1[(2 5 8± 11 7)ng/ml]高于对照组 [(7 5± 3 9)ng/ml],P <0 0 1。TGF - β1的含量随着肿瘤临床分期增加而升高 (P <0 0 5 )。结论 宫颈癌患者血清TGF - β1含量与肿瘤的发生、发展有关。
出处 《广东医学》 CAS CSCD 2004年第10期1162-1163,共2页 Guangdong Medical Journal
基金 广西壮族自治区科技厅自然科学基金资助项目 (编号 :桂科自0 2 2 90 5 0 )
  • 相关文献

参考文献9

  • 1Markowits SD, Rpberts AB. Tumor suppressor activity of the TGF- pathway in human cancers. Cytoking Growth Factor Rev, 1996,7:93 被引量:1
  • 2Shim KS, KimHan WS, Woon SH, et al. Elevated serum levels of transforming growth factor- beta in patients with colorectal carcinoma. Cancer,1999,85(3): 554 被引量:1
  • 3Tsushima H, Kawata S, Tamura S, et al. High levels of transforming growth factor beta 1 in patients with colorectal cancer. Gastroctenology,1996, 110(2) :375 被引量:1
  • 4Alan DL, Harinder SG. Transforming growth factor- beta 1. Cancer,1999, 85(3):517 被引量:1
  • 5Kong FM, Washington MK, Jirtke RL, et al. TGF- beta 1 reflect disease status in patients with ling cancer after radiotherapy. Ling Cancer, 1996,10:47 被引量:1
  • 6Tsai JF, Jeng JE, Chuang LY, et al. Elevated uriny transforming growth factor- beta 1 level as a tumor marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. Br J Cancer, 1997, 76(2) :244 被引量:1
  • 7Thampson TC, Truong LD, Timme TL, et al. Transforming growth factor beta 1 as a biomarker for prostate cancer. J Cell Biochem Supple, 1992,16H:54 被引量:1
  • 8Eder IE, Scenzl A, Hobisch A, et al. Expression of transforming growth factors beta 1, beta 2 and beta 3 in human bladder carcinomas. Br J Cancer, 1997,75(12): 1753 被引量:1
  • 9Chopra V, Dihm TV, Hanningn EV, et al. Serum levels of interleukins growth factors and angiogenin in patients with endometrial cancer. J Cancer Rea Clin Oncol, 1997,123:167 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部